Jury Awards Damages for Edgeworth Client in Patent Infringement Suit

An Edgeworth Economics client, Royal DSM, a Netherlands-based biotechnology firm, was awarded damages in a patent infringement matter before the United States District Court for the Western District of Wisconsin. Defendants were accused of infringing DSM’s patent—which relates to strains of genetically-modified yeast used in the production of bioethanol—through the sale of their yeast products known as TransFerm Yield+ and YP3.

Edgeworth Partner Dr. Jesse David testified at trial regarding a reasonable royalty owed to DSM as a result of the alleged infringement. The jury determined that DSM’s valid patent had been infringed and awarded damages of $14.5 million.